Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QBTS vs GSK✓SelectedUSD · GSKQBTS vs GSK performance historyLatest closeAs of-4.83%11/18
Stock and ETF performance explorer

QBTS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-24.2%
GSK return
+66.0%
Excess return
-90.2%
Maximum drawdown
-96.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.8%-1.3%-3.5%-4.7%
7D-27.8%-3.1%-24.7%-27.6%
30D-35.0%-0.9%-34.1%-34.9%
3M-60.6%-4.2%-56.5%-60.5%
6M-59.7%-1.6%-58.1%-59.6%
YTD-70.6%+2.6%-73.2%-70.8%
1Y-66.5%+6.2%-72.7%-66.9%
3Y+795.2%+55.0%+740.3%+746.3%
5Y-21.9%+42.8%-64.8%-22.9%
All-24.2%+66.0%-90.2%-24.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling